Tumor budding is an independent adverse prognostic factor of pancreatic ductal adenocarcinoma patients treated by resection after preoperative chemoradiotherapy.
Hayasaki A, Mizuno S, Usui M, Kaluba B, Komatsubara H, Sakamoto T, Maeda K, Shinkai T, Noguchi D, Ito T, Gyoten K, Iizawa Y, Fujii T, Tanemura A, Murata Y, Kuriyama N, Watanabe M, Uchida K, Kishiwada M.
Hayasaki A, et al. Among authors: fujii t.
Pancreas. 2024 Dec 2. doi: 10.1097/MPA.0000000000002440. Online ahead of print.
Pancreas. 2024.
PMID: 39626198